Sai Life Sciences Ltd (SAILIFE)
₹1,579.20
Mkt cap
₹33,650 Cr
P/E ratio
91.50
P/B
13.50
Div yield
0.00%
ROE
15.40%
ROCE
19.60%
EPS (TTM)
₹17.26
Book value
₹117
52W range
795–1,587
Sector
Healthcare
Price history
Previous close
Incorporated in 1999, Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industries [1]
NSE SAILIFEBSE 544306
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthHigh
TechnicalsBullish
52-week range
−0.49% from high₹1,579
₹795+98.64% from low₹1,587
Current
₹1,579.20
Prev close
₹1,584.90
Day
−0.36%
Price performance
1D
−0.36%
1W
+8.19%
1M
+15.68%
3M
+28.42%
6M
+57.24%
1Y
+86.87%
YTD
+71.34%
Financials
Revenue, profit & margin
P/E ratio
91.5×
SAILIFE is 169% above the sector median of 34.0×
SAILIFE91.5×
Sector median34.0×
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 384 | 439 | 280 | 396 | 440 | 580 | 496 | 537 | 556 | 602 | 554 | |
| Expenses | 287 | 315 | 254 | 293 | 320 | 422 | 375 | 392 | 369 | 426 | 406 | |
| Operating Profit | 96 | 125 | 26 | 102 | 120 | 158 | 121 | 146 | 188 | 177 | 148 | |
| OPM % | 25% | 28% | 9% | 26% | 27% | 27% | 24% | 27% | 34% | 29% | 27% | |
| Other Income | 11 | 3 | 8 | 10 | 9 | 10 | 10 | 15 | 0 | 16 | 4 | |
| Interest | 23 | 21 | 21 | 21 | 23 | 11 | 12 | 9 | 10 | 8 | 8 | |
| Depreciation | 31 | 31 | 31 | 36 | 34 | 37 | 38 | 40 | 44 | 45 | 46 | |
| Profit before tax | 53 | 76 | -18 | 55 | 72 | 119 | 81 | 112 | 134 | 139 | 98 | |
| Tax % | 25% | 26% | -25% | 25% | 25% | 26% | 25% | 25% | 25% | 25% | 25% | |
| Net Profit | 40 | 56 | -14 | 42 | 54 | 88 | 60 | 84 | 100 | 104 | 73 | |
| EPS in Rs | 2.59 | 4.24 | 2.90 | 4.00 | 4.75 | 4.92 | 3.45 | |||||
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.15% · closed higher next day 5 of last 7
| Q3FY25 | Q4FY25† | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | |
|---|---|---|---|---|---|---|---|
| Broadcast | 7 Feb '25◦ | 14 May '25◦ | 7 Aug '25◦ | 6 Nov '25◦ | 5 Feb '26◦ | 14 May '26◦ | 6 Aug '26◦ |
| Earnings day | −4.43% | +4.45% | +4.59% | −5.08% | +4.80% | −1.94% | −3.42% |
| +1 day | −9.67% | +4.11% | +12.85% | −1.65% | +10.21% | +0.04% | +0.90% |
| +5 days | −11.10% | +2.05% | +13.72% | −5.46% | +12.83% | +0.12% | +2.58% |
| +15 days | −3.74% | +0.56% | +4.28% | −4.11% | +23.11% | +7.38% | +5.06% |
| +30 days | −1.49% | +4.63% | +12.72% | −0.51% | +21.87% | +10.95% | — |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202634.53%Promoter
Promoters34.53%0.08
FIIs19.65%1.52
DIIs32.71%1.17
Public13.11%0.42
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | ₹1,899.00 | 36.07 | 4,55,634 | 0.84% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| DIVISLAB | ₹9,100.00 | 81.09 | 2,41,576 | 0.33% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| TORNTPHARM | ₹4,857.00 | 82.80 | 1,84,745 | 0.78% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| CIPLA | ₹1,385.00 | 31.26 | 1,11,888 | 0.94% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| ZYDUSLIFE | ₹1,120.00 | 22.95 | 1,11,720 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| LAURUSLABS | ₹1,840.00 | 90.93 | 99,417 | 0.11% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| LUPIN | ₹2,110.00 | 16.20 | 96,483 | 0.85% | 1,417 | +16.08% | 8,277 | +32.04% | 29.93% |
| SAILIFE | ₹1,584.30 | 91.51 | 33,650 | 0.00% | 73 | +21.22% | 554 | +11.66% | 19.65% |
| Median: 158 Co. | ₹421.50 | 33.96 | 2,277 | 0.08% | 13 | +30.25% | 164 | +18.67% | 14.96% |
Filings
Annual reports2
Concall transcripts20
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Sep - Sai Life Sciences to attend Jefferies 5th India Forum on 18 September 2026 in Gurgaon.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 SepAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 1 Sep - Allotment of 80,600 Equity shares having Face Value ?1/- each as per Company''s ESOP PlansAnnouncement under Regulation 30 (LODR)-Newspaper Publication 26 Aug - Newspaper Publication relating to 27th AGM (Post-dispatch Advt.)Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015 25 Aug - Web-link sent for FY2025-26 annual report; 27th AGM on September 17, 2026.